Pulling SEC filings + quote and writing the call…

BELDEN INC.
Next earnings Jul 29, 2026 (before open) · consensus $2.04 EPS, $753M rev
Last earnings -11.8% on 2026-04-30
Belden grew revenue 10% and EPS 23% with a 19% ROE as it shifts toward higher-value networking solutions; fair at 20.9x.
Revenue $2.72B · FY2025
Quality fundamentals and an attractive price line up (~75% below fair value) — the rarer case where both the business and the entry look good.
Belden has been transforming from a commoditized cable maker into a higher-value provider of complete network connectivity and data-infrastructure solutions, and FY2025 shows the strategy gaining traction. Revenue grew 10.3% to $2.72B — re-accelerating after a flat FY2023-2024 — while net income rose 19.7% to $238M and diluted EPS jumped 23.1% to $5.91, the EPS outpacing net income thanks to a 3.8% reduction in shares. Operating income grew 18.5% to $316M (11.6% operating margin) and the gross margin held a solid 38.0%, evidence the solutions mix shift and pricing discipline are improving profitability. ROE of 18.8% is attractive.
The company is investing for growth: R&D rose 14.6% to $129M and capex grew 5.5% to $136M, positioning Belden for demand tied to industrial automation, broadband/fiber buildout, and data-center connectivity. Operating cash flow of $355M comfortably funds that investment plus capital returns. The balance sheet is reasonable, though long-term debt rose 13.8% to $1.29B (against $390M cash and $1.26B equity) — bearing watching but well within a manageable range for a business generating strong cash flow. Buybacks (shares -3.8%) are the primary capital-return lever; the dividend is token.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:58 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.30B | $2.61B | $2.51B | $2.46B | $2.72B |
| Gross profit | $772M | $916M | $955M | $922M | $1.03B |
| Operating income | $264M | $363M | $318M | $266M | $316M |
| Net income | $63.9M | $255M | $243M | $198M | $238M |
| Diluted EPS | $1.41 | $5.72 | $5.66 | $4.80 | $5.91 |
| Net margin | 2.8% | 9.8% | 9.7% | 8.1% | 8.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0000913142, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/21/2026, 8:58:27 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-05-21 | McCray Gregory James Director | Award | 1.53K | |
| 2026-05-21 | Lee Vivie Director | Award | 1.53K | |
| 2026-05-21 | KLEIN JONATHAN C Director | Award | 1.53K | |
| 2026-05-21 | Calderon Nancy E. Director | Award | 1.53K | |
| 2026-05-21 | Brown Judy L Director | Award | 1.53K | |
| 2026-05-21 | Brink Diane D Director | Award | 1.53K | |
| 2026-05-21 | BALK LANCE C Director | Award | 1.53K | |
| 2026-05-21 | AL-SALEH ADEL Director | Award | 1.53K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.